As of May 2024 KalVista Pharmaceuticals has a market cap of $0.51 Billion. This makes KalVista Pharmaceuticals the world's 5985th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.51 B | 20.88% |
2023 | $0.42 B | 154.38% |
2022 | $0.16 B | -48.59% |
2021 | $0.32 B | -4.99% |
2020 | $0.34 B | 7.27% |
2019 | $0.31 B | -6.64% |
2018 | $0.34 B | 223.55% |
2017 | $0.10 B | 49.85% |
2016 | $70.17 M | -26.36% |
2015 | $95.28 M |
On May 2nd, 2024 the market cap of KalVista Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.65 B | 27.93% | ๐บ๐ธ USA |